Timoptol 0.25 %. Timoptol 0.5 % 2.5 mg/ 5.0 mg Ophthalmic Solution
PDF Leaflet Revision Date: 06 December 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of elevated intraocular pressure in glaucoma and ocular hypertension.
Dosage (summary)
1 drop in each affected eye twice daily; may switch to once daily if stable.
Onset of Action / Duration
Onset: 20 mins, Duration: up to 24 hours
Special Populations
- Paediatric patients
- Elderly patients
Pregnancy & Breastfeeding
Not recommended in pregnancy; detectable in breast milk.
Key Drug Interactions
- CYP2D6 inhibitors
- Calcium channel blockers
- Digitalis glycosides
Contraindications
- Hypersensitivity to timolol
- Bradycardia
- Asthma
- COPD
Common side effects
- Ocular irritation
- Dry eyes
- Bradycardia
- Dizziness
Counselling Points
- Avoid contact lenses during use
- Monitor for respiratory symptoms
- Report any severe side effects
Serious warnings
- Caution in respiratory diseases
- Monitor for cardiac effects
- Risk of systemic absorption
Important Disclaimer
The Timoptol 0.25 %. Timoptol 0.5 % 2.5 mg/ 5.0 mg Ophthalmic Solution professional information leaflet below is the property of Mundipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
